Catalyst Wire Dossier Catalyst Wire Dossier

TAVABOROLE TOPICAL SOLUTION, 5%

tavaborole · Encube Ethicals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAVABOROLE TOPICAL SOLUTION, 5%, covering 2020-10-13 to 2020-10-13. Get the full timeline:

Most recent: FDA Approved: TAVABOROLE — Original Application (Encube Ethicals, Inc.)

See pricing